EVENTS

Course Agenda


Please note all times are in Eastern Time

 

MONDAY May 12

   
  9:00 am

Welcome and Agenda Overview

Valentina Nardi, MD

Massachusetts General Hospital

  9:10 am

Technology: Nucleic Acids Extraction, Pre-Analytic Considerations 

Yi Ding, MD, PhD

Geisinger Health

 

9:55 am

Break

 

  10:05 am

Technology: Sanger Sequencing with Clinical Examples

Kevin Fisher, MD, PhD

Baylor College of Medicine

 

10:50 am

Break

 

  11:00 am

Identity Testing with Case Studies

Jesse Cox, MD, PhD, A(ACHI)

University of Nebraska Medical Center

  12:00 pm

Lunch

 

  12:40 pm

Technology: Nucleic Acid Amplification Techniques with Clinical Examples

Eric Vail, MD

Cedars-Sinai Medical Center

  1:25 pm

Break

 

  1:35 pm

Technology: NGS I

Jason N. Rosenbaum, MD

Kaiser Permanente, Northern California

  2:50 pm

Break

 

 

  3:00 pm

Technology: NGS II

Jason N. Rosenbaum, MD

  4:15 pm

Break

 

  4:25 pm

Meet the Faculty

 
       
 

TUESDAY, May 13

   
  9:00 am

Welcome and Updates

Valentina Nardi, MD

  9:02 am

NGS - Methylation Sequencing with Clinical Examples

Matija Snuderl

NYU Langone Health

  9:50 am

Break

 

  10:00 am

Pharmacogenomics with Clinical Examples

Ann Moyer, MD, PhD

Mayo Clinic

  11:15 am

Break

 

 

  11:25 am

NGS Bioinformatics

Jason N. Rosenbaum, MD

  12:40 pm

Lunch

 
  1:42 pm

Cytogenetics I: Chromosome Banding Analysis and FISH with Clinical Examples

Adrian Dubuc, PhD, FACMG

Roswell Park

  2:20 pm

Break

 

  2:30 pm

Cytogenetics II: 'Molecular' Cytogenetic Approaches (Chromosomal Microarray ,Optical Genome Mapping, etc) with Clinical Examples

Adrian Dubuc, PhD, FACMG

 

  3:45 pm

Break

 

  3:55 pm

Meet the Faculty

 

       

WEDNESDAY, May 14

  9:00 am

Welcome and Updates

Valentina Nardi, MD

  9:02 am

Germline and Somatic Variant Interpretation with Clinical Examples

Alanna Church, MD, PhD 

Boston's Children's Hospital

  10:30 am

Break

 

  10:40 am

Inherited Conditions I with Clinical Examples

Pinar Bayrak-Toydemir, MD

University of Utah/ARUP Laboratories

  11:25 am

Break

 

  11:35 am

Inherited Conditions II with Clinical Examples

Pinar Bayrak-Toydemir, MD

  12:20 pm

Lunch

 
  1:00 pm

Math 101: Applications of Bayesian Analysis in Molecular Testing

Annette Kim, MD

University of Michigan/Michigan Medicine

  2:45 pm

Break

 
  2:55 pm

Germline Cancer Syndromes

Diana Mandelker, MD

Memorial Sloan Kettering

  3:55 pm

Break

 

  4:05 pm

Meet the Faculty

 

       

THURSDAY, May 15

  9:00 am

Welcome and Updates

Valentina Nardi, MD

  9:02 am

Molecular Oncology I with Clinical Examples

Laura Tafe, MD

Memorial Sloan Kettering

  10:15 am

Break

 

  10:25 am

Molecular Oncology II with Clinical Examples

Laura Tafe, MD

 

  11:40 am

Break

 

  11:50 am

Molecular Oncology III with Clinical Examples

Laura Tafe, MD

  1:05 pm

Lunch

 
  1:45 pm

Infectious Diseases I: Overview of an Appropriate Infectious Diseases Molecular Menu and How It Should be Used with Clinical Examples

Erin Graf, PhD, D(ABMM)

Mayo Clinic Arizona

  2:45 pm

Break

 
  2:55 pm

Infectious Diseases II: Important Limitations and Stewardship Approaches to Infectious Disease Molecular Testing with Clinical Examples

Erin Graf, PhD, D(ABMM)

  3:50 pm

Break

 
  4:00 pm

Meet the Faculty

 
       
 

FRIDAY May 16

   
  9:00 am

Welcome and Final Updates

Valentina Nardi, MD

  9:02 am

Pattern Recognition in Myeloid Neoplasms with Clinical Examples

Annette Kim, MD

  10:45 am

Break

 
  10:55 am

Molecular Pathology Pearls in Lymphoid Malignancies

Rena Xian, MD

Johns Hopkins University School of Medicine

  12:40 pm

Lunch

 
  1:20 pm

HLA with Clinical Examples

Ryan Peña, MD

Tufts Medicine

  2:20 pm

Break

 
  2:30 pm

Key Molecular Laboratory management Concepts that Impact Patient Care

Erin Graf, PhD, D(ABMM)

  3:20 pm

Break

 
  3:30 pm

Laboratory Finances: Reimbursement, Laboratory Budgets and Implications for your Routine Practice

Erin Graf, PhD, D(ABMM)

 

  4:30 pm

Meet the Faculty (includes closing remarks and adjournment)

 

Corporate Partners